Amarin Added to NASDAQ Biotechnology Index
Get Alerts AMRN Hot Sheet
Join SI Premium – FREE
BEDMINSTER, NJ and DUBLIN, IRELAND -- (Marketwired) -- 12/14/15 -- Amarin Corporation plc (NASDAQ: AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced that it has been selected for addition to the NASDAQ Biotechnology Index effective December 21, 2015.
The NASDAQ Biotechnology Index is designed to track the performance of a set of NASDAQ-listed securities that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). These companies must meet eligibility requirements, including minimum market capitalization, average daily trading volume, and seasoning as a public company, among other criteria. The index is re-ranked annually and serves as the basis for the iShares NASDAQ Biotechnology Index Fund. For more information about the NASDAQ Biotechnology Index, including eligibility criteria, visit https://indexes.nasdaqomx.com/.
About Amarin
Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Amarin's clinical program includes commitment to an ongoing outcomes study. Vascepa® (icosapent ethyl), Amarin's first FDA approved product, is a highly-pure, EPA-only, omega-3 fatty acid product available by prescription. For more information about Vascepa visit www.vascepa.com. For more information about Amarin visit www.amarincorp.com.
Investor Relations: Kathryn McNeil or Michael Farrell Investor Relations and Corporate Communications Amarin Corporation plc In U.S.: +1 (908) [email protected] Morrell Trout Group In U.S.: +1 (646) [email protected] Inquiries:Lee Davies Makovsky In U.S.: +1 (212) [email protected]
Source: Amarin Corp. Plc
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Building Your Credit: Applying for Credit Cards Online Responsibly
- Top South Florida accounting firm Garcia Santa Maria PLLC launches new audit practice and announcement of audit partners joining the firm.
- Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates
Create E-mail Alert Related Categories
Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!